Search

everythinglearnresearchcommunity

for

Search:↓

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

The review found that the way Platelet-Rich Plasma is made varies a lot, which can change the results of medical treatments.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Exosomes could improve skin and hair treatments but are limited by cost, production difficulty, and need for more research.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Finasteride improves prostate cancer detection in PSA test.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Some birth control pills have a higher risk of blood clots than others.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Consider benefits and risks of new alopecia treatments for safety.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.